F. Benedetti, Placebo Effects: Understanding the Mechanisms in Health and Disease, 2009.
DOI : 10.1093/acprof:oso/9780198705086.001.0001

T. Kaptchuk and C. Kerr, Placebo controls, exorcisms, and the devil, The Lancet, vol.374, issue.9697, p.1234, 2009.
DOI : 10.1016/S0140-6736(09)61775-X

J. Ioannidis, Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philos Ethics Humanit Med, p.14, 2008.

I. Kirsch, B. Deacon, T. Huedo-medina, A. Scoboria, T. Moore et al., Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration, PLoS Medicine, vol.80, issue.2, p.45, 2008.
DOI : 10.1371/journal.pmed.0050045.sd001

J. Fournier, R. Derubeis, S. Hollon, S. Dimidjian, J. Amsterdam et al., Antidepressant Drug Effects and Depression Severity, JAMA, vol.303, issue.1, pp.47-53, 2010.
DOI : 10.1001/jama.2009.1943

J. Moncrieff, The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment. Revised Edition, 2009.
DOI : 10.1057/9780230589445

A. Cipriani, T. Furukawa, G. Salanti, J. Geddes, J. Higgins et al., Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, The Lancet, vol.373, issue.9665, pp.746-758, 2009.
DOI : 10.1016/S0140-6736(09)60046-5

M. Hamilton, A RATING SCALE FOR DEPRESSION, Journal of Neurology, Neurosurgery & Psychiatry, vol.23, issue.1, pp.56-62, 1960.
DOI : 10.1136/jnnp.23.1.56

S. Montgomery and M. Asberg, A new depression scale designed to be sensitive to change, The British Journal of Psychiatry, vol.134, issue.4, pp.382-389, 1979.
DOI : 10.1192/bjp.134.4.382

F. Naudet, A. Maria, and B. Falissard, Antidepressant Response in Major Depressive Disorder: A Meta-Regression Comparison of Randomized Controlled Trials and Observational Studies, PLoS ONE, vol.300, issue.6, p.20811, 2011.
DOI : 10.1371/journal.pone.0020811.s002

L. Hedges and I. Olkin, Statistical Methods for Meta-analysis, 1985.

A. Glenny, D. Altman, F. Song, C. Sakarovitch, J. Deeks et al., Indirect comparisons of competing interventions, Health Technology Assessment, vol.9, issue.26, pp.1-134, 2005.
DOI : 10.3310/hta9260

J. Jansen, R. Fleurence, B. Devine, R. Itzler, A. Barrett et al., Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1, Value in Health, vol.14, issue.4, pp.417-428, 2011.
DOI : 10.1016/j.jval.2011.04.002

D. Hoaglin, N. Hawkins, J. Jansen, D. Scott, R. Itzler et al., Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2, Value in Health, vol.14, issue.4, pp.429-437, 2011.
DOI : 10.1016/j.jval.2011.01.011

J. Sterne, A. Sutton, J. Ioannidis, N. Terrin, D. Jones et al., Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials, BMJ, vol.343, issue.jul22 1, p.4002, 2011.
DOI : 10.1136/bmj.d4002

R. Development and C. Team, R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.

G. Schwarzer and . Meta, Meta-Analysis with R, R Package version 11?8. Vienna: The Comprehensive R Archive Network, 2010.

. Lumley, T: rmeta: Meta-analysis, R package version 216. Vienna: The Comprehensive R Archive Network, 2009.

D. Maechler, lme4: Linear Mixed-effects Models Using S4 Classes, R Package Version 0999375?32. Vienna: The Comprehensive R Archive Network, 2009.

A. Liberati, D. Altman, J. Tetzlaff, C. Mulrow, P. Gotzsche et al., The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration, PLoS Medicine, vol.4, issue.7, p.1000100, 2009.
DOI : 10.1371/journal.pmed.1000100.s002

J. Higgins, S. Thompson, J. Deeks, and D. Altman, Measuring inconsistency in meta-analyses, BMJ, vol.327, issue.7414, pp.557-560, 2003.
DOI : 10.1136/bmj.327.7414.557

M. Bauer, P. Tharmanathan, H. Volz, H. Moeller, and N. Freemantle, The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression, European Archives of Psychiatry and Clinical Neuroscience, vol.61, issue.3, pp.172-185, 2009.
DOI : 10.1007/s00406-008-0849-0

A. Alkhafaji, L. Trinquart, G. Baron, M. Desvarieux, and P. Ravaud, Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants, BMC Medicine, vol.26, issue.1, p.142, 2012.
DOI : 10.2165/00019053-200826070-00006
URL : https://hal.archives-ouvertes.fr/inserm-00764321

F. Song, I. Harvey, and R. Lilford, Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions, Journal of Clinical Epidemiology, vol.61, issue.5, pp.455-463, 2008.
DOI : 10.1016/j.jclinepi.2007.06.006

J. Jansen and H. Naci, Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers, BMC Medicine, vol.31, issue.1, p.159, 2013.
DOI : 10.1002/sim.5442

M. Egger, G. Smith, and J. Sterne, Uses and abuses of meta-analysis, Clinical Medicine, vol.1, issue.6, pp.478-484, 2001.
DOI : 10.7861/clinmedicine.1-6-478

J. Greene and A. Kesselheim, Why Do the Same Drugs Look Different? Pills, Trade Dress, and Public Health, New England Journal of Medicine, vol.365, issue.1, pp.83-89, 2011.
DOI : 10.1056/NEJMhle1101722

D. Altman and J. Bland, Absence of evidence is not evidence of absence, Australian Veterinary Journal, vol.6, issue.4, p.485, 1995.
DOI : 10.1016/0140-6736(93)91758-E

E. Turner, A. Matthews, E. Linardatos, R. Tell, and R. Rosenthal, Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy, New England Journal of Medicine, vol.358, issue.3, pp.252-260, 2008.
DOI : 10.1056/NEJMsa065779

D. Eyding, M. Lelgemann, U. Grouven, M. Harter, M. Kromp et al., Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials, BMJ, vol.341, issue.oct12 1, p.4737, 2010.
DOI : 10.1136/bmj.c4737

L. Trinquart, A. A. Ravaud, and P. , Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials, PLoS ONE, vol.303, issue.4, p.35219, 2012.
DOI : 10.1371/journal.pone.0035219.s007

T. Wu, Y. Li, Z. Bian, G. Liu, and D. Moher, Randomized trials published in some Chinese journals: how many are randomized?, Trials, vol.16, issue.2, p.46, 2009.
DOI : 10.1136/bmj.319.7203.160

J. Ioannidis, Ranking antidepressants, The Lancet, vol.373, issue.9677, pp.1759-1760, 2009.
DOI : 10.1016/S0140-6736(09)60974-0

J. Lexchin, L. Bero, B. Djulbegovic, and O. Clark, Pharmaceutical industry sponsorship and research outcome and quality: systematic review, BMJ, vol.326, issue.7400, pp.1167-1170, 2003.
DOI : 10.1136/bmj.326.7400.1167
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC156458

J. Ioannidis, Why Most Published Research Findings Are False, PLoS Medicine, vol.13, issue.8, p.124, 2005.
DOI : 10.1371/journal.pmed.0020124.t004

B. Pescosolido, J. Martin, J. Long, T. Medina, J. Phelan et al., ???A Disease Like Any Other???? A Decade of Change in Public Reactions to Schizophrenia, Depression, and Alcohol Dependence, American Journal of Psychiatry, vol.167, issue.11, pp.1321-1330, 2010.
DOI : 10.1176/appi.ajp.2010.09121743

J. Moncrieff and D. Cohen, Do Antidepressants Cure or Create Abnormal Brain States?, PLoS Medicine, vol.2, issue.7, p.240, 2006.
DOI : 10.1371/journal.pmed.0030240.sd001

J. Lacasse and J. Leo, Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature, PLoS Medicine, vol.162, issue.12, p.392, 2005.
DOI : 10.1371/journal.pmed.0020392.t002

T. Jefferson, Ranking antidepressants, The Lancet, vol.373, issue.9677, pp.1759-1761, 2009.
DOI : 10.1016/S0140-6736(09)60973-9

S. Schwan and P. Hallberg, Ranking antidepressants, The Lancet, vol.373, issue.9677, pp.1761-1761, 2009.
DOI : 10.1016/S0140-6736(09)60977-6

M. Seyringer and S. Kasper, Ranking antidepressants, The Lancet, vol.373, issue.9677, pp.1760-1761, 2009.
DOI : 10.1016/S0140-6736(09)60976-4

E. Turner, S. Moreno, and A. Sutton, Ranking antidepressants, The Lancet, vol.373, issue.9677, pp.1760-1761, 2009.
DOI : 10.1016/S0140-6736(09)60975-2

G. Gartlehner, B. Gaynes, R. Hansen, P. Thieda, A. Deveaugh-geiss et al., Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians, Annals of Internal Medicine, vol.149, issue.10, pp.734-750, 2008.
DOI : 10.7326/0003-4819-149-10-200811180-00008

G. Patrick, G. Combs, and T. Gavagan, Initiating antidepressant therapy? Try these 2 drugs first, J Fam Pract, vol.58, pp.365-369, 2009.

A. Lakoff, The Mousetrap: Managing the Placebo Effect in Antidepressant Trials, Molecular Interventions, vol.2, issue.2, pp.72-76, 2002.
DOI : 10.1124/mi.2.2.72

K. Thomas, General practice consultations: is there any point in being positive?, BMJ, vol.294, issue.6581, pp.1200-1202, 1987.
DOI : 10.1136/bmj.294.6581.1200

A. Handel, S. Patel, J. Pakpoor, G. Ebers, B. Goldacre et al., High reprint orders in medical journals and pharmaceutical industry funding: case-control study, BMJ, vol.344, issue.jun28 1, p.4212
DOI : 10.1136/bmj.e4212